He et al. found that metformin can activate AMPK to stimulate the JNK1-BCL2 signaling pathway, cause Bcl-2 and Beclin-1 dissociation, restore autophagy, and alleviate diabetic cardiomyopathy (61). Here, BCL2 is linked to diabetic cardiomyopathy.